Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In this study, we defined the role of peroxisome proliferator-activated receptor β/δ (PPARδ) in metabolic homeostasis by using subtype selective agonists. Analysis of rat L6 myotubes treated with the PPARδ subtype-selective agonist, GW501516, by the Affymetrix oligonucleotide microarrays revealed that PPARδ controls fatty acid oxidation by regulating genes involved in fatty acid transport, β-oxidation, and mitochondrial respiration. Similar PPARδ-mediated gene activation was observed in the skeletal muscle of GW501516-treated mice. Accordingly, GW501516 treatment induced fatty acid β-oxidation in L6 myotubes as well as in mouse skeletal muscles. Administration of GW501516 to mice fed a high-fat diet ameliorated diet-induced obesity and insulin resistance, an effect accompanied by enhanced metabolic rate and fatty acid β-oxidation, proliferation of mitochondria, and a marked reduction of lipid droplets in skeletal muscles. Despite a modest body weight change relative to vehicle-treated mice, GW501516 treatment also markedly improved diabetes as revealed by the decrease in plasma glucose and blood insulin levels in genetically obese ob / ob mice. These data suggest that PPARδ is pivotal to control the program for fatty acid oxidation in the skeletal muscle, thereby ameliorating obesity and insulin resistance through its activation in obese animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, SIRT1 activators like resveratrol and NAD+ precursors have been shown to enhance mitochondrial biogenesis and oxidative metabolism, leading to improved muscle function and recovery”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, PPAR agonists, such as pioglitazone (PPAR-γ) and the investigational GW501516 (PPAR-δ), have been shown in clinical and preclinical studies to enhance lipid metabolism and insulin sensitivity”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Treating mice with PPARα or PPARβ/δ agonists also induces, either directly or indirectly, an increase in whole body oxygen consumption without affecting caloric intake, thus accounting for lower rates of weight gain in response to high fat feeding (Guerre-Millo et al., 2000; Tanaka et al., 2003).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Tanaka et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
Research works printed but not linked: 1
- Dressel, U., Allen, T. L., Pippal, J. B., Rohde, P. R., Lau, P. & Muscat, G. E. (2003) Mol Endocrinol., in press. [DOI] [PubMed]
Cited by
Items 601–700 of 860
Manio, M. C. C., Matsumura, S., & Inoue, K. (2018) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-018-0234-y · Cited by 14
Zhou, Z., Deng, L., Hu, L., Ren, Q., Cai, Z., Wang, B., Li, Z., & Zhang, L. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173300 · Cited by 12
PPARgamma agonist pioglitazone does not enhance performance in mice
Sanchis‐Gomar, F., Pareja-Galeano, H., & Martinez-Bello, V. E. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1587 · Cited by 12
Takeshita, S., Suzuki, T., Kitayama, S., Moritani, M., Inoue, H., & Itakura, M. (2012) · Genes & Genetic Systems · doi:10.1266/ggs.87.253 · Cited by 12
Perreault, M., Will, S., Panza, D., Gareski, T., Harding, K., Kubasiak, D., Jalenak, M., Gartrell, K., Wang, S., Bollag, G. E., et al. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01157.x · Cited by 12
Physiological ligands of PPARs in inflammation and lipid homeostasis
Lathion, C., Michalik, L., & Wahli, W. (2006) · Future Lipidology · doi:10.2217/17460875.1.2.191 · Cited by 12
Finck, B. N. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.2.161 · Cited by 17
Peroxisome proliferator-activated receptor antagonists as emerging therapeutics in cancer treatment
Misal, S., Patil, V. M., Ramaa, C. S., & Lavecchia, A. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108693 · Cited by 18
PPAR δ : A Potential Therapeutic Target for the Treatment of Metabolic Hypertension
Jiang, Y., Li, Q., Jia, M., & Yan, Z. (2019) · International Journal of Hypertension · doi:10.1155/2019/7809216 · Cited by 11
Zhao, T., Ma, A., Huang, Z., Liu, Z., Sun, Z., Zhu, L., & Chang, H. (2024) · Fish Physiology and Biochemistry · doi:10.1007/s10695-024-01313-w · Cited by 12
Cyclodextrin-Clathrated Limonin Suppresses Diet-Induced Obesity in Mice
Halder, D., Das, N. D., Jung, K. H., Choi, M., Kim, M. S., Lee, S. R., & Chai, Y. G. (2013) · Journal of Food Biochemistry · doi:10.1111/jfbc.12040 · Cited by 11
Fuentes, E., & Palomo, I. F. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.04.027 · Cited by 13
Kim, K., Ahn, N., Jung, S., & Park, S. (2017) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2017.21.6.633 · Cited by 11
Lu, H.-Y., Zeng, H., Zhang, L., Porres, J. M., & Cheng, W.-H. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.06.004 · Cited by 11
Generation and characterization of a humanized PPARδ mouse model
Gross, B. S., Hennuyer, N., Bouchaert, E., Rommens, C., Grillot, D., Mezdour, H., & Staels, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01359.x · Cited by 11
Miller, A. R. (2006) · Drug Development Research · doi:10.1002/ddr.20125 · Cited by 12
The roles ofPPARsin human diseases
Li, J., & Liu, Y. (2018) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2018.1475673 · Cited by 13
Transcriptional Regulation of Metabolic Switching PDK4 Gene under Various Physiological Conditions
Araki, M., Nozaki, Y., & Motojima, K. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.153 · Cited by 12
The Molecular Basis of PPAR Function
Barak, Y., & Lee, C. (2010) · PPAR Research · doi:10.1155/2010/510530 · Cited by 15
Nrf2 modulates the benefits of evening exercise in type 2 diabetes
Fasipe, B., & Laher, I. (2023) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2023.09.001 · Cited by 13
Novel investigational drugs mimicking exercise for the treatment of cachexia
Penna, F., Pin, F., Ballarò, R., Baccino, F. M., & Costelli, P. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1117072 · Cited by 10
Okazaki, S., Shioi, R., Noguchi‐Yachide, T., Ishikawa, M., Makishima, M., Hashimoto, Y., & Yamaguchi, T. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.08.067 · Cited by 11
Li, J., Xu, S., Liu, Y., Yan, Z., Zhang, F., Lv, Q., & Tong, N. (2019) · Lipids · doi:10.1002/lipd.12182 · Cited by 12
D’Annibale, O., Phua, Y. L., Land, C. V., Karunanidhi, A., Dorenbaum, A., Mohsen, A.-W. A., & Vockley, J. (2022) · Cells · doi:10.3390/cells11172635 · Cited by 11
CYP450, COX-2 and Obesity Related Renal Damage
Imig, J. D., Zhao, X., Dey, A., & Shaw, M. (2005) · Toxicology Mechanisms and Methods · doi:10.1080/15376520590918856 · Cited by 10
Ham, J., & Kang, H. (2005) · Tetrahedron Letters · doi:10.1016/j.tetlet.2005.07.145 · Cited by 10
Nuclear Receptors in the Regulation of Lipid Metabolism
Mello, T. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0080-1 · Cited by 12
Wu, J.-X., Chen, L., Ding, F., Chen, L.-Z., & Gu, Y. (2016) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-016-9442-8 · Cited by 10
Kim, H., & Ye, J. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000048 · Cited by 10
Toledo, F. G. S., & Kelley, D. E. (2005) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000155365.26870.64 · Cited by 11
Organelle Communication with the Nucleus
Sengupta, S., & Levy, D. L. (2024) · Results and problems in cell differentiation · doi:10.1007/978-3-031-62036-2_1 · Cited by 11
Kato, T., Fukao, K., Ohara, T., Naya, N., Tokuyama, R., Muto, S., Fukasawa, H., Itai, A., & Matsumura, K. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00932 · Cited by 9
Pharmacogenetics of the PPAR Genes and Cardiovascular Disease
Cresci, S. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.11.1581 · Cited by 9
Contemporary and Novel Therapeutic Options for Hypertriglyceridemia
Bell, D. A., & Watts, G. F. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.08.001 · Cited by 11
Hu, L., Zhou, Z., Deng, L., Ren, Q., Cai, Z., Wang, B., Zheng, L., & Wang, G. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13342 · Cited by 10
Liu, S., Reilly, S. M., & Lee, C. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4413 · Cited by 10
Increased glucose utilization and decreased fatty acid metabolism in myotubes fromGlmpgt/gtmice
Kong, X. Y., Feng, Y., Eftestøl, E., Kase, E. T., Haugum, H., Eskild, W., Rustan, A. C., & Thoresen, G. H. (2016) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2015.1120752 · Cited by 10
Transcriptional regulation of peroxisome proliferator-activated receptors and liver X receptors
Villacorta, L., Garcia-Barrio, M. T., & Chen, Y. E. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0024-5 · Cited by 10
Glicocorticóides e síndrome metabólica: aspectos favoráveis do exercício físico nesta patofisiologia
Pauli, J. R., Souza, L. S., Rogatto, G. P., Gomes, R., & Luciano, E. (2006) · Revista Portuguesa de Ciências do Desporto · doi:10.5628/rpcd.06.02.217 · Cited by 21
Selective, potent PPARγ agonists with cyclopentenone core structure
Otero, M. P., Pérez‐Santín, E., Rodríguez‐Barrios, F., Vaz, B., & de Lera, Á. R. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.072 · Cited by 11
Hua, C., Geng, Y., Niu, L., Chen, Q., Cai, L., Tao, S., Ni, Y., & Zhao, R. (2018) · Livestock Science · doi:10.1016/j.livsci.2018.05.020 · Cited by 14
Clayton, S. A., Mizener, A. D., Whetsell, M., Rentz, L. E., Meadows, E. M., Geldenhuys, W. J., & Pistilli, E. E. (2024) · Cancers · doi:10.3390/cancers16213640 · Cited by 6
Norikura, T., Kajiya, S., Sugawara, M., Kubo, M., Fukuyama, Y., & Sato, S. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103632 · Cited by 9
Tachibana, K., Fukuda, S., Fukushima, J., Ishimoto, K., Sakata, M., Nishimori, Y., & Doi, T. (2022) · International Journal of Cosmetic Science · doi:10.1111/ics.12767 · Cited by 8
Self-citationBiological evaluation of novel benzisoxazole derivatives as PPARδ agonists
Sakuma, S., Endo, T., Kanda, T., Nakamura, H., Yamasaki, S., & Yamakawa, T. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.053 · Cited by 8
Ordelheide, A., Heni, M., Thamer, C., Machicao, F. E., Fritsche, A., Stefan, N., Häring, H., & Staiger, H. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02547.x · Cited by 8
Oh, J., Lee, Y., Han, Y., Kim, J., Park, C., Oh, D.-R., Yun, H., Lee, G., Kim, J., & Choi, C. (2020) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2020.25.4.380 · Cited by 10
An update on current type 2 diabetes mellitus (T2DM) druggable targets and drugs targeting them
Uniyal, P., Panwar, S., Bhatt, A., Marianesan, A. B., Kumar, R., Singh, T. G., Tyagi, Y., Bushi, G., Gaidhane, A. M., & Kumar, B. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11149-y · Cited by 11
Sun, Y., Wang, Z., Nie, C., Xue, L., Wang, Y., Song, C., Fan, M., Qian, H., Ying, H., Li, Y., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c06034 · Cited by 8
PPARβ/δ as a promising molecular drug target for liver diseases: A focused review
Meng, X., Wang, L., Du, Y.-C., Cheng, D., & Zeng, T. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102343 · Cited by 8
Mitochondrial Metabolism and Insulin Action
Turner, N. A. (2013) · InTech eBooks · doi:10.5772/56449 · Cited by 13
Synthesis, Biological Evaluation and Molecular Modeling of GW 501516 Analogues
Ciocoiu, C. C., Ravna, A. W., Sylte, I., & Hansen, T. V. (2010) · Archiv der Pharmazie · doi:10.1002/ardp.201000189 · Cited by 7
PPARδ Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities
Perreault, M., Erbe, D. V., & Tobin, J. F. (2008) · PPAR Research · doi:10.1155/2008/125387 · Cited by 9
Suzuki, M., Nakamura, F., Taguchi, E., Nakata, M., Wada, F., Takihi, M., Inoue, T., Ohta, S., & Kawachi, H. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3270-7 · Cited by 7
Yadav, D. K., Shrestha, S., Dadhwal, G., & Chandak, G. R. (2018) · Epigenomics · doi:10.2217/epi-2017-0139 · Cited by 10
Effects of adipokine zinc-α2-glycoprotein on adipose tissue metabolism after dexamethasone treatment
Qiao, Y., Fan, G., Guo, J., Gao, S., Zhao, R., & Yang, X. (2018) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2018-0165 · Cited by 7
Cruz, B. O. D., Cardozo, L., Magliano, D. C., & Stockler‐Pinto, M. B. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuz058 · Cited by 8
Genetic Dissection of the Physiological Role of Skeletal Muscle in Metabolic Syndrome
Hagiwara, N. (2014) · New Journal of Science · doi:10.1155/2014/635146 · Cited by 10
Peroxisome Proliferator-Activated Receptor β/δ: A novel target for the reduction of atherosclerosis
Gross, B. S., Fruchart, J., & Staels, B. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.08.009 · Cited by 8
PPAR δ Activity in Cardiovascular Diseases: A Potential Pharmacological Target
Tesse, A., Andriantsitohaina, R., & Ragot, T. (2009) · PPAR Research · doi:10.1155/2009/745821 · Cited by 9
Pereyra, A. S., Wang, Z.-M., Messi, M. L., Zhang, T., Wu, H., Register, T. C., Forbes, E., Devarie‐Baez, N. O., Files, D. C., Abba, M. C., et al. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw192 · Cited by 7
Rivera, C. N., Hinkle, J. S., Watne, R. M., Macgowan, T. C., Wommack, A. J., & Vaughan, R. A. (2023) · PPAR Research · doi:10.1155/2023/4779199 · Cited by 7
Liu, H., Yang, T., & Choi, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1580559 · Cited by 11
Xiang, L., Wang, L., Xia, Y. Y., Wang, Y., Shi, J., Zhang, C., Xie, L., Ru, Y., Cheng, C. K., Pu, Y., et al. (2024) · The Innovation Life · doi:10.59717/j.xinn-life.2024.100065 · Cited by 6
Diaz, N. P., Lione, L. A., Hutter, V., & Mackenzie, L. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063158 · Cited by 6
Nonalcoholic Fatty Liver Disease
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_9 · Cited by 6
Li, J., Zhang, D.-D., Jiang, G., Li, X., Zhang, C., Zhou, M., Liu, W., & Xu, W. (2015) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2015.07.004 · Cited by 6
Myers, R. B., & Yoshioka, J. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00169.2015 · Cited by 7
Ciocoiu, C. C., Ravna, A. W., Sylte, I., Rustan, A. C., & Hansen, T. V. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.10.020 · Cited by 6
Ding, H., Zhang, Y., Liu, L., Yuan, H., Qu, J., & Shen, R. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.116772 · Cited by 7
GW501516 acts as an efficient PPARα activator in the mouse liver
Terada, M., Araki, M., Ashibe, B., & Motojima, K. (2011) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2011.v5.4.176 · Cited by 6
Shioi, R., Okazaki, S., Noguchi‐Yachide, T., Ishikawa, M., Makishima, M., Hashimoto, Y., & Yamaguchi, T. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.037 · Cited by 6
Lee, S. R., Jo, S. L., Heo, J. H., Kim, T., Lee, K. P., & Hong, E. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.153974 · Cited by 7
Vascular smooth muscle cell dysfunction in diabetes: nuclear receptors channel to relaxation
Doyon, G., & Bruemmer, D. (2016) · Clinical Science · doi:10.1042/cs20160518 · Cited by 6
Palomer, X., Wang, J.-R., Tang, X., Wu, S., Rodríguez‐Calvo, R., Wahli, W., & Vázquez‐Carrera, M. (2026) · Cells · doi:10.3390/cells15050464 · Cited by 5
Wang, C., Batey, R. G., Yamahara, J., & Li, Y. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.06.040 · Cited by 5
Role of PPARs and their isoforms in metabolic disorders related to insulin resistance and diabetes
Кравченко, Н. А., & Yarmysh, N. V. (2011) · Cytology and Genetics · doi:10.3103/s0095452711030042 · Cited by 4
Genomics of Aerobic Capacity and Endurance Performance: Clinical Implications
Pitsiladis, Y. P., Wang, G., & Wolfarth, B. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-355-8_8 · Cited by 7
Jaswal, J. S., Cadete, V. J. J., & Lopaschuk, G. D. (2008) · Heart and Metabolism · Cited by 5
Kato, T., Ohara, T., Suzuki, N., Naya, N., Fukao, K., Tokuyama, R., Muto, S., Fukasawa, H., Itai, A., & Matsumura, K. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117215 · Cited by 5
Gul, F., Parvaiz, N., & Azam, S. S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283743 · Cited by 6
Nuclear Receptors in the Control of Lipid Metabolism
Reilly, S. M., & Lee, C. (2007) · Springer eBooks · doi:10.1007/978-0-387-72347-1_6 · Cited by 5
Miyachi, H., & Hashimoto, Y. (2008) · PPAR Research · doi:10.1155/2008/689859 · Cited by 5
Simonson, G. D., & Kendall, D. M. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000216965.36504.be · Cited by 5
V., D. C. E. M. (2006) · Frontiers in bioscience · doi:10.2741/2125 · Cited by 5
THE METABOLIC SYNDROME IN HYPERTENSION
Redon, J., Martinez, F., & Fabia, M. J. (2014) · CRC Press eBooks · doi:10.1201/b17072-46 · Cited by 5
Jannat, A., Chinnathambi, S., Packirisamy, G., Leon, B. S., Karthikeyan, S., Mangaiyarkarasi, R., Taniguchi, Y., & Pandian, G. N. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00721 · Cited by 4
A Combination of Soy Isoflavone and L-Carnitine Improves Running Endurance in Mice
Lee, J. R., Joh, Y., Choi, C., Kim, K., & Lee, Y. (2023) · Nutrients · doi:10.3390/nu15173678 · Cited by 4
Alessi, D., McCreery, C. V., & Zomorrodi, A. R. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1586750 · Cited by 6
Development of Synthetic Modulators of PPARs: Current Challenges and Future Opportunities
Pinaire, J. A., Miller, A. R., & Gregoire, F. M. (2008) · PPAR Research · doi:10.1155/2008/786359 · Cited by 4
PPARs: Important Regulators in Metabolism and Inflammation
Sanderson, L. M., & Kersten, S. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_10 · Cited by 7
PPRESearch: Peroxisome Proliferator Activator Element Search Database
Venkatachalam, G., Sakharkar, M. K., Kumar, A. P., & Clement, M. (2009) · National University of Singapore · Cited by 7
Wang, F., Wu, Y., Xie, X., Sun, J., & Chen, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.012 · Cited by 4
Bao, T., Wang, S., Yang, Y., He, L., Han, L., Zhai, T., Chen, J., Zhou, Q., Zhao, X., Lian, F., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.817147 · Cited by 5
Do PPARs play a role in cardiac hypertrophy and heart failure?
Tian, Q., & Barger, P. M. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.011 · Cited by 4
Prognostic Role of Metabolic Syndrome in the Elderly is Not Greater Than the Sum of Its Components
Mazza, A., Pessina, A. C., Zamboni, S., & Casiglia, E. (2010) · Aging Health · doi:10.2217/ahe.10.9 · Cited by 4
Domańska-Senderowska, D., Snochowska, A., Szmigielska, P., Jastrzębski, Z., Jegier, A., Kiszałkiewicz, J., Dróbka, K., Jastrzębska, J., Pastuszak‐Lewandoska, D., Cięszczyk, P., et al. (2018) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2018-0008 · Cited by 5
Peroxisome Proliferator–Activated Receptors and The Metabolic Syndrome
Meiliana, A., & Wijaya, A. (2009) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v1i1.79 · Cited by 8
Gemmink, A., van de Weijer, T., Schaart, G., Grabner, G. F., Moonen‐Kornips, E., Knoops, K., Zechner, R., Schweiger, M., & Hesselink, M. K. C. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2025.159703 · Cited by 5
Koh, Y., Kamchonemenukool, S., Ho, P.-Y., Weerawatanakorn, M., & Pan, M. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c10351 · Cited by 3
Metadata
- Authors
- Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., Watanabe, Y., Uchiyama, Y., Sumi, K., Iguchi, H., Ito, S., Doi, T., Hamakubo, T., Naito, M., Auwerx, J., Yanagisawa, M., Kodama, T., & Sakai, J.
- Affiliations
- Tohoku University (JP)
- Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo 153-8904, Japan; Pharmacology II, Department of Research and Development, Grelan Pharmaceutical Co. Ltd., Tokyo 205-8501, Japan; Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan; Yanagisawa Orphan Receptor Project, Exploratory Research for Advanced Technology, Japan...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-12-15
- Volume
- 100
- Issue
- 26
- Pages
- 15924-15929
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC307669
- OpenAlex
- W1982027543
- Cited by
- 832
- References
- 18
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 16 · 2023: 16 · 2022: 21 · 2021: 32 · 2020: 36 · 2019: 13 · 2018: 42 · 2017: 28 · 2016: 25 · 2015: 33 · 2014: 36 · 2013: 35 · 2012: 39
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- PPARδ, fatty acid beta-oxidation, skeletal muscle, metabolic syndrome, GW501516, insulin resistance, obesity, high-fat diet, mitochondrial respiration, fatty acid uptake, lipid droplets, diabetes mellitus, ob/ob mice, metabolic rate
- MeSH terms
- Animals, Dimethyl Sulfoxide, Enzymes, Fatty Acids, Nonesterified, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Oxidation-Reduction, Thiazoles, Transcription Factors, Receptors, Cytoplasmic and Nuclear, Muscle, Skeletal, Metabolic Syndrome, Lipid Metabolism, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.